サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390729

3Dバイオプリンティング市場レポート：コンポーネント、用途、エンドユーザー、地域別、2023-2028年

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
3Dバイオプリンティング市場レポート：コンポーネント、用途、エンドユーザー、地域別、2023-2028年
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の3Dバイオプリンティング市場規模は、2022年に10億3,200万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに26億2,100万米ドルに達し、2022-2028年の成長率（CAGR）は16.81％になると予測しています。老年人口の増加、研究開発（R&D）活動への注力の高まり、市場破壊の少なさなどが市場を牽引する主な要因です。

高齢人口の増加が市場の成長を促進

高齢人口の増加は現在、3Dバイオプリンティング市場を牽引する主な要因の1つとなっています。老年人口は慢性疾患にかかりやすいため、臓器移植の需要が増加しています。さらに、さまざまな医療技術が幅広く利用可能であることや、業界における有能な専門家の存在が市場の成長を支えています。

本レポートでは、市場構造、主要企業による市場シェア、主要企業の市況分析、主要成功戦略、競合ダッシュボード、企業評価象限などの競合分析を行っています。また、主要企業の詳細プロファイルも掲載しています。市場構造は中程度に断片化されており、業界には多数の地域および世界プレーヤーが存在します。3Dバイオプリンティング業界では、設備投資が高く、参入・撤退の障壁が高いため、新規参入者の数は中程度です。さらに、この業界では、複数のメーカー間の差別化がほとんどないため、製品の差別化は緩やかです。

3Dバイオプリンティングとは？

3次元（3D）バイオプリンティングは、精密な解剖学的組織を開発するために設計された付加製造法を指します。直接描画、レーザー描画、マイクロスタンプ、フォトリソグラフィ、ステレオリソグラフィ、エレクトロプリンティング、インクジェット描画など、さまざまな成膜・組み立てプロセスで構成されます。組織や臓器の3D構造を作成するために、生きた細胞、生体材料、活性生体分子を使用して製造される細胞ベースのバイオインクの分解に依存しています。骨、皮膚、軟骨、血管移植片、気管スプリント、心臓組織など、多数の複雑な身体構造を構築するために、生体材料を多層に堆積させる。その結果、3Dバイオプリンティングは世界中の病院、研究機関、学術機関、バイオ製薬会社で広く利用されています。

COVID-19の影響：

COVID-19パンデミックの発生は、さまざまな業界に深刻な問題を引き起こし、多くの国に前例のない課題を課しました。しかし、3Dバイオプリンティングは、COVID-19パンデミックの間、ヘルスケア産業において不可欠な技術として台頭しました。医療製品が手に入らなかったり不足したりしたため、3Dバイオプリント臓器の需要が高まっています。これに加えて、さまざまな企業が最先端の3Dバイオプリンティング・プラットフォームを使用して、SARS-CoV-2感染ヒト気道および肺オルガノイド・モデルを作製していました。さらに、これらのモデルはCOVID-19の病勢進行の研究や迅速な薬剤スクリーニングにも使用されていました。世界中でCOVID-19患者が増加しているため、バイオプリンターの利用が増加しています。これとは別に、パンデミックは生産工程の減少により3Dバイオプリンティング市場に若干の支障をきたしました。さまざまな主要メーカーが、パンデミックの最初の数カ月間、ウイルスの蔓延により生産工程の一時停止や休止を余儀なくされました。

3Dバイオプリンティング市場の動向：

現在、動物実験を最小限に抑えようという消費者の意識が高まっていることが、市場にプラスの影響を与えている主な要因の1つです。これに加えて、さまざまな慢性疾患にかかりやすい高齢者の間で3Dバイオプリンティングの需要が高まっており、市場の見通しが明るいです。さらに、臓器オンチップの開拓など、さまざまな技術の進歩が市場の成長を後押ししています。これとは別に、世界中の大衆の間で再生医療、がん治療、幹細胞ソリューションに対する需要が高まっていることも、市場の成長に寄与しています。さらに、ヘルスケア産業における3Dバイオプリンティングの採用が増加していることも、市場破壊の少ない市場であることから、市場の成長を支えています。さらに、主なメーカーは研究開発（R&D）活動に注力し、新機軸のコストを削減し、新薬の発見プロセスを強化するためにバイオプリント組織を導入しています。

本レポートで扱う主な質問

  • 2022年の世界の3Dバイオプリンティング市場規模は？
  • 2023-2028年の世界の3Dバイオプリンティング市場の予想成長率は？
  • 世界の3Dバイオプリンティング市場を牽引する主な要因は？
  • COVID-19が世界の3Dバイオプリンティング市場に与えた影響は？
  • 世界の3Dバイオプリンティング市場のコンポーネント別内訳は？
  • 3Dバイオプリンティングの世界市場の用途別区分は？
  • エンドユーザー別3Dバイオプリンティングの世界市場の内訳は？
  • 世界の3Dバイオプリンティング市場の主要地域は？
  • 世界の3Dバイオプリンティング市場の主要プレーヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の3Dバイオプリンティング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：コンポーネント別

  • 3Dバイオプリンター
    • 市場動向
    • 主要セグメント
      • シリンジ/押出バイオプリンティング
      • インクジェットバイオプリンティング
      • 磁気浮上式バイオプリンティング
      • レーザー支援バイオプリンティング
      • その他
    • 市場予測
  • 足場
    • 市場動向
    • 市場予測
  • バイオマテリアル
    • 市場動向
    • 主要セグメント
      • 生体細胞
      • ハイドロゲル
      • 細胞外マトリックス
      • その他
    • 市場予測

第7章 市場内訳：用途別

  • 調査
    • 市場動向
    • 主要セグメント
      • 医薬品調査
      • 再生医療
      • 3D細胞培養
    • 市場予測
  • 臨床
    • 市場動向
    • 主要セグメント
      • 皮膚
      • 骨と軟骨
      • 血管
      • その他
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 研究機関・学術機関
    • 市場動向
    • 市場予測
  • バイオ医薬品企業
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • 3D Systems Inc.
    • Aspect Biosystems Ltd.
    • Cellink
    • Cyfuse Biomedical K.K.
    • EnvisionTEC GmbH（Desktop Metal Inc.）
    • GeSiM-Gesellschaft fur Silizium-Mikrosysteme mbH
    • Materialise
    • Organovo Holdings Inc.
    • Poietis
    • RegenHU
    • Stratasys Ltd.
図表

List of Figures

  • Figure 1: Global: 3D Bioprinting Market: Major Drivers and Challenges
  • Figure 2: Global: 3D Bioprinting Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: 3D Bioprinting Market: Breakup by Component (in %), 2022
  • Figure 5: Global: 3D Bioprinting Market: Breakup by Application (in %), 2022
  • Figure 6: Global: 3D Bioprinting Market: Breakup by End User (in %), 2022
  • Figure 7: Global: 3D Bioprinting Market: Breakup by Region (in %), 2022
  • Figure 8: Global: 3D Bioprinting (3D Bioprinters) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: 3D Bioprinting (3D Bioprinters) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: 3D Bioprinting (Scaffolds) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: 3D Bioprinting (Scaffolds) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: 3D Bioprinting (Biomaterials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: 3D Bioprinting (Biomaterials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: 3D Bioprinting (Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: 3D Bioprinting (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: 3D Bioprinting (Clinical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: 3D Bioprinting (Clinical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: 3D Bioprinting (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: 3D Bioprinting (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: 3D Bioprinting (Research Organization and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: 3D Bioprinting (Biopharmaceuticals Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: 3D Bioprinting Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: 3D Bioprinting Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: 3D Bioprinting Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: 3D Bioprinting Industry: SWOT Analysis
  • Figure 74: Global: 3D Bioprinting Industry: Value Chain Analysis
  • Figure 75: Global: 3D Bioprinting Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: 3D Bioprinting Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: 3D Bioprinting Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 3: Global: 3D Bioprinting Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: 3D Bioprinting Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: 3D Bioprinting Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: 3D Bioprinting Market: Competitive Structure
  • Table 7: Global: 3D Bioprinting Market: Key Players
目次
Product Code: SR112023A4556

Abstract

The global 3D bioprinting market size reached US$ 1,032 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,621 Million by 2028, exhibiting a growth rate (CAGR) of 16.81% during 2022-2028. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market.

Rising Geriatric Population Augmenting Market Growth

The rising geriatric population currently represents one of the primary factors driving the 3D bioprinting market. There is an increase in the demand for organ transplantation among the geriatric population, as they are more prone to chronic diseases. Moreover, the wide availability of various medical technologies and the presence of competent specialists in the industry is supporting the growth of the market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of numerous regional and global players in the industry. The volume of new entrants is moderate in the 3D bioprinting industry due to the high capital investments and excessive entry and exit barriers. Moreover, the product differentiation is moderate in the industry due to little differentiation between several manufacturers.

What is 3D Bioprinting?

Three-dimensional (3D) bioprinting refers to an additive manufacturing method designed for the development of precise anatomical tissues. It comprises various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. It relies on the decomposition of cell-based bio-inks that are manufactured using living cells, biomaterials, and active biomolecules to create 3D structures of tissues and organs. It deposits multiple layers of biomaterials to build numerous complex bodily structures, such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. As a result, 3D bioprinting is widely utilized in hospitals, research organizations, academic institutes, and biopharmaceutical companies across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak caused severe problems for various industries and imposed unprecedented challenges on numerous countries. But 3D bioprinting has emerged as a vital technology in the healthcare industry during the COVID-19 pandemic. There was an increased demand for 3D bioprinted organs due to the unavailability or shortage of medical products. In addition to this, various companies were using state-of-the-art 3D bioprinting platforms to fabricate SARS-CoV-2-infected human airway and lung organoid models. Moreover, these models were being used to study COVID-19 disease progression and for rapid drug screening. There was an increased utilization of bioprinters on account of the rising COVID-19 cases across the globe. Apart from this, the pandemic has slightly hampered the 3D bioprinting market due to the reduction in the production process. Various key manufacturers were forced to temporarily shut down or pause their production process for the first few months of the pandemic due to the widespread of the virus.

3D Bioprinting Market Trends:

At present, the increasing awareness among consumers to minimize animal testing represents one of the major factors influencing the market positively. Besides this, the growing demand for 3D bioprinting among the geriatric population, as they are more prone to various chronic diseases, is offering a positive market outlook. In addition, various technological advancements, such as the development of organ-on-a-chip, is propelling the growth of the market. Apart from this, the increasing demand for regenerative medicines, cancer therapeutics, and stem cell solutions among the masses around the world is contributing to the growth of the market. Moreover, the rising adoption of 3D bioprinting in the healthcare industry, as it is a less disrupted market, is supporting the growth of the market. Furthermore, key manufacturers are focusing on research and development (R&D) activities to introduce bioprinted tissues to reduce the cost of new innovations and enhance the process of finding new drugs.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, application and end user.

Component Insights:

3D Bioprinters

Syringe/Extrusion Bioprinting

Inkjet Bioprinting

Magnetic Levitation Bioprinting

Laser-assisted Bioprinting

Others

Scaffolds

Biomaterials

Living Cells

Hydrogels

Extracellular Matrices

Others

The report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment due to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. In addition to this, the rising awareness among individuals about the 3D bioprinters technology is bolstering the growth of the market.

Application Insights:

Research

Drug Research

Regenerative Medicine

3D Cell Culture

Clinical

Skin

Bone and Cartilage

Blood Vessels

Others

A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share, as 3D printing technology is widely utilized among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans.

End User Insights:

Hospitals

Research Organization and Academic Institutes

Biopharmaceuticals Companies

A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share due to the increasing number of target therapies. In addition, the rising collaborations and mergers among biopharmaceutical companies to develop 3D bioprinting is positively influencing the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North America 3D bioprinting market included the growing prevalence of various chronic diseases, presence of key players, and increasing private and government investment. Moreover, the introduction of laser bio-printing method that can make live 3D printed bio-tissues to create artificial tissues is positively influencing the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

3D Systems Inc.

Aspect Biosystems Ltd.

Cellink

Cyfuse Biomedical K.K.

EnvisionTEC GmbH (Desktop Metal Inc.)

GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH

Materialise

Organovo Holdings Inc.

Poietis

RegenHU

Stratasys Ltd.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global 3D bioprinting market in 2022?
  • 2. What is the expected growth rate of the global 3D bioprinting market during 2023-2028?
  • 3. What are the key factors driving the global 3D bioprinting market?
  • 4. What has been the impact of COVID-19 on the global 3D bioprinting market?
  • 5. What is the breakup of the global 3D bioprinting market based on the component?
  • 6. What is the breakup of the global 3D bioprinting market based on the application?
  • 7. What is the breakup of the global 3D bioprinting market based on the end user?
  • 8. What are the key regions in the global 3D bioprinting market?
  • 9. Who are the key players/companies in the global 3D bioprinting market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global 3D Bioprinting Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 3D Bioprinters
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Syringe/Extrusion Bioprinting
      • 6.1.2.2 Inkjet Bioprinting
      • 6.1.2.3 Magnetic Levitation Bioprinting
      • 6.1.2.4 Laser-assisted Bioprinting
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Scaffolds
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biomaterials
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Living Cells
      • 6.3.2.2 Hydrogels
      • 6.3.2.3 Extracellular Matrices
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Drug Research
      • 7.1.2.2 Regenerative Medicine
      • 7.1.2.3 3D Cell Culture
    • 7.1.3 Market Forecast
  • 7.2 Clinical
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Skin
      • 7.2.2.2 Bone and Cartilage
      • 7.2.2.3 Blood Vessels
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Organization and Academic Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Biopharmaceuticals Companies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3D Systems Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aspect Biosystems Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Cellink
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Cyfuse Biomedical K.K.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 EnvisionTEC GmbH (Desktop Metal Inc.)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 GeSiM - Gesellschaft fur Silizium-Mikrosysteme mbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Materialise
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Organovo Holdings Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Poietis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 RegenHU
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Stratasys Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials